Marvel Highlights New Published Research of Its SAB Member Professor David Blum @marvelbiotechnology #Chemicals #Biotechnology #OTC #OTCMarkets #OTCStocks #SmallCaps #TSXV #Investing

Calgary, Alberta--(Newsfile Corp. - July 9, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to highlight the recently published paper "Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP/PS1 mice" by a member of its scientific advisory board, Dr. David Blum and colleagues (PMID 3896478). In this study, published in the leading neurological journal...


http://dlvr.it/T9MhWb

Comments

Popular posts from this blog

SEC Investor Advisory Committee to Discuss Exempt Offerings and Accredited Investors at September 21 Meeting #Banking #FinancialServices

Cleantek Industries Inc. Announces a Twelve-Month Extension of Credit Facility #CTEK.CA #CTEK.V #GLKFF #Investing #OTC #OTCMarkets #OTCStocks #SmallCaps #TSXV #Technology

International Property Alerts: Global Property Exhibition Singapore 2025 Highlights London's Best New Developments #Advertising